logo
Select company
Select metric
$ -41.08MConsolidated Income
VS
Market
21
Sector
43
Industry
40
History
72
$ 6.42Close
$ 4.4 - $ 34 52-Week Range
Ticker Information

Ticker

BDSX

Company Name

BIODESIX INC

Sector

Healthcare

Industry

Diagnostics & Research

Exchange

NASDAQ

BIODESIX INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

BDSX - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -41.08M
3/31/2025$ -40.42M
12/31/2024$ -42.93M
9/30/2024$ -43.82M
6/30/2024$ -44.51M
3/31/2024$ -47.06M
12/31/2023$ -52.15M
9/30/2023$ -63.34M
6/30/2023$ -66.09M
3/31/2023$ -68.56M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • BIODESIX INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -30.73M.
  • Over the past 5 years, BIODESIX INC's average Cons. Inc. has been $ -48.06M.
  • The median Cons. Inc. for BIODESIX INC during this period was $ -44.51M
  • BIODESIX INC reached its highest Cons. Inc. over the past 5 years at $ -30.73M.
  • The lowest Cons. Inc. recorded by BIODESIX INC in the same timeframe $ -68.56M

BIODESIX INC's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
TELA : TELA BIO INC $ -40.77MLUNG : PULMONX CORP $ -56.94MFONR : FONAR CORP $ 10.67MFBIO : FORTRESS BIOTECH INC $ -89.35MSTRR1 : STAR EQUITY HOLDINGS INC $ -2.15MSTRO : SUTRO BIOPHARMA INC $ -208.7MVNRX : VOLITIONRX LTD $ -23.52MMYO : MYOMO INC $ -9.32MIMDX : INSIGHT MOLECULAR DIAGNOSTICS INC $ -63.42MAPYX : APYX MEDICAL CORP $ -17.29M

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

BDSX - Consolidated Income, Last 5 years

$ -68.56M

Minimum

Mar 31, 2023

$ -30.73M

Maximum

Dec 31, 2019

$ -48.06M

Average

$ -44.51M

Median

Cons. Inc. Benchmark Analysis

The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.05M with a standard deviation of $ 116.48M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.05M
median$ -2.09M
std$ 116.48M